Healthlinx Signs $9M Financing Deal to Drive Expansion of OvPlex into US
December 16, 2011
Healthlinx Signs $9M Financing Deal to Drive Expansion of OvPlex into US
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Court Approves Sale of Correlogic’s Assets to Vermillion after Second Bidder Drops Out
December 2, 2011 / ProteoMonitor - Vermillion Buys Correlogic's Assets for $435K; Correlogic Settles with LabCorp, Quest
November 11, 2011 / ProteoMonitor - Is Healthlinx Eyeing Purchase of Correlogic's Assets as Part of Move into US Cancer Dx Market?
October 14, 2011 / ProteoMonitor - HealthLinx Restarts Sales of OvPlex Ovarian Cancer Test, Launches 1,150-Patient International Trial
June 18, 2010 / ProteoMonitor - UPDATE: Vermillion Repays Quest $5.9M, Ending Companies' Credit Agreement
October 19, 2012 / ProteoMonitor